DESCRIPTION OF SERUM GLUTAMIC OXALOACETIC TRANSAMINASE (SGOT) IN LUNG TUBERCULOSIS ADVANCED STAGE TREATMENT IN THE REGION THE WORK OF THE KABILA PUSKESMAS IN 2020

Abstrak

Tuberculosis is a contagious infectious disease caused by the bacteria Mycobacterium tuberculosis. The incidence of tuberculosis is a serious problem, especially the side effects of the drugs Isoniazid and Rifampicin. This could potentially lead to an increase in SGOT levels, so monitoring liver function needs to be done as an additional measure in routine examination of tuberculosis patients.

The purpose of this study was to describe the levels of Serum Glutamic Oxaloacetic Transaminase (SGOT) in advanced stage treatment of pulmonary tuberculosis in the Kabila Public Health Center in 2020. This research is descriptive using a quantitative approach. The population involved in this study were all patients who have been obtaining the advanced treatment of pulmonary tuberculosis. The total of these samples were 28 people. The sampling method uses total sampling. Examination of SGOT levels used the IFCC kinetic method and was checked using a tool Spectrophotometer CHEM-7. Data were analyzed by univariate. The results show that 5 samples (17,9%) and 23 samples (82,1%) are abnormal levels of SGOT. SGOT levels that do not increase or are declared normal are because pulmonary tuberculosis patients consume OAT regularly and adopt a healthy lifestyle.

The conclusion is that patients with advanced treatment pulmonary tuberculosis experienced an increase in SGOT levels less than normal. The need to maintain a healthy lifestyle such as adequate rest during treatment for pulmonary tuberculosis sufferers so as not to experience an increase in SGOT levels.